‹ ›
MYP_119789
← PREVIOUS NEXT → BACK
Basic Information
LP-54
Antimicrobial
Antiviral
Antiviral ▸ Anti-HIV ▸ Anti-HIV-1
Antiviral ▸ Antiviral mechanism ▸ Viral fusion inhibition
not Standard
25 amino acids
-
contains X representing unresolved or non-standard residue
Sequence
YTSLIEELIKKSEEQQKKNEEELKX
Physicochemical Analysis
0.00 Da
0.00
0.00
0.00
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0229735 VERIFIED: YES
Provenance & Taxonomy
Synthetic construct [Synthetic]
HR2 fusion-inhibitory peptide
32630
Structure & Mods
linear peptide [Linear]
noncanonical stereochemical modification [Modified]
Acetylation
Amidation
Contains X placeholder residue(s), The 'X' at position 25 is Lys-C16(palmitic acid)
Bio-Activity Profile
Anti-HIV-1 Fusion inhibition Antiviral
HIV-1 NL4-3 | TZM-bl cells
0.000301±0.000026 μM
IC50
Mammalian: 2.8 h; Yeast: 10 min; E. coli: 2 min
PaperStructural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus. | Chong H, Zhu Y, Yu D, He Y. | J Virol. 2018 Sep 26;92(20):e01088-18. | DOI:10.1128/JVI.01088-18 | PMID:30089693 PMID30089693 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/30089693/
RECORD: Rec_0245544 VERIFIED: YES
Provenance & Taxonomy
Synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
stereochemistry not fully specified; contains X placeholder [Modified]
Acetylation
Amidation
Contains X placeholder residue(s), The 'X' at position 25 is Lys-C16(palmitic acid)
Bio-Activity Profile
Antiviral Antimicrobial
HIV-1 HXB2; TZM-bl cells
0.000149±0.000048 μM
IC50
PaperStructural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus. J Virol. 2018 Sep 26;92(20):e01088-18. doi: 10.1128/JVI.01088-18. PMID: 30089693. PMID30089693 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/30089693/
RECORD: Rec_0248474 VERIFIED: NO
Provenance & Taxonomy
Synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
stereochemistry not fully specified; contains X placeholder [Modified]
Acetylation
Amidation
Contains X placeholder residue(s), The 'X' at position 25 is Lys-C16(palmitic acid)
Bio-Activity Profile
Antimicrobial Antiviral
PaperStructural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus. J Virol. 2018 Sep 26;92(20):e01088-18. doi: 10.1128/JVI.01088-18. PMID: 30089693. PMID30089693 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/30089693/
RECORD: Rec_0309252 VERIFIED: YES
Provenance & Taxonomy
Synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
stereochemistry not fully specified; contains X placeholder [Modified]
Contains X placeholder residue(s), unspecified non-canonical residue at 25
Bio-Activity Profile
Antiviral
HIV-1 NL4-3 PsV
Virus inhibition assay
PMID30089693 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/30089693/
RECORD: Rec_0354060 VERIFIED: YES
Provenance & Taxonomy
Synthetic construct [Synthetic]
HR2 fusion-inhibitory peptide
32630
Structure & Mods
linear peptide [Linear]
noncanonical stereochemical modification [Modified]
Acetylation
Amidation
Contains X placeholder residue(s), The 'X' at position 25 is Lys-C16(palmitic acid)
Bio-Activity Profile
Anti-HIV-1 Fusion inhibition Antiviral
HIV-1 JRCSF | TZM-bl cells
0.001796±0.00034 μM
IC50
Mammalian: 2.8 h; Yeast: 10 min; E. coli: 2 min
PaperStructural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus. | Chong H, Zhu Y, Yu D, He Y. | J Virol. 2018 Sep 26;92(20):e01088-18. | DOI:10.1128/JVI.01088-18 | PMID:30089693 PMID30089693 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/30089693/
FIRST PREV 1 2
Showing 5 records · Page 2 of 2